§

Ex Parte Varkey

13107252 (P.T.A.B. Aug. 25, 2016)
Ex Parte Varkey

8 Cited authorities

  1. Rowe v. Dror

    112 F.3d 473 (Fed. Cir. 1997)   Cited 229 times   3 Legal Analyses
    Finding that "balloon angioplasty catheter" in preamble to claim was structural limitation

  2. Gillette Co. v. Energizer Holdings, Inc.

    405 F.3d 1367 (Fed. Cir. 2005)   Cited 156 times   2 Legal Analyses
    Holding party to “blatant admission” in argument made to EPO

  3. Mars, Inc. v. H.J. Heinz Co., L.P.

    377 F.3d 1369 (Fed. Cir. 2004)   Cited 109 times   1 Legal Analyses
    Holding that "mixture" is an open-ended term

  4. Leapfrog v. Fisher-Price

    485 F.3d 1157 (Fed. Cir. 2007)   Cited 90 times   5 Legal Analyses
    Holding that the objective considerations of nonobviousness presented, including substantial evidence of commercial success, praise, and long-felt need, were inadequate to overcome a strong showing of primary considerations that rendered the claims at issue invalid

  5. In re Taylor

    484 F. App'x 540 (Fed. Cir. 2012)

    2012-1006 06-14-2012 IN RE JASON ARTHUR TAYLOR, REBECCA ANN ZELTINGER, AND JOHN G. COSBY, JR. JASON ARTHUR TAYLOR, Technology Advancement Labs LLC, of Kensington, Maryland, pro se. JOHN G. COSBY, Technology Advancement Labs LLC, of Kensington, Maryland, pro se. REBECCA ANN ZELTINGER, Technology Advancement Labs LLC, of Kensington, Maryland, pro se. RAYMOND T. CHEN, Solicitor, Office of the Solicitor, United States Patent and Trademark Office, of Alexan- dria, Virginia, for appellee David J. Kappos

  6. Section 103 - Conditions for patentability; non-obvious subject matter

    35 U.S.C. § 103   Cited 6,157 times   488 Legal Analyses
    Holding the party seeking invalidity must prove "the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains."

  7. Section 6 - Patent Trial and Appeal Board

    35 U.S.C. § 6   Cited 188 times   63 Legal Analyses
    Giving the Director authority to designate "at least 3 members of the Patent Trial and Appeal Board" to review "[e]ach appeal, derivation proceeding, post-grant review, and inter partes review"

  8. Section 41.37 - Appeal brief

    37 C.F.R. § 41.37   Cited 32 times   25 Legal Analyses
    Requiring identification of support in specification and, for means-plus-function limitations, corresponding structure as well